Fibrillization of α-synuclein and tau in familial Parkinson's disease caused by the A53T α-synuclein mutation

Experimental Neurology

Volumn 187, Issue 2, 2004, Pages 279-288

  Kotzbauer, Paul T ^a,b   Giasson, Benoit I ^a   Kravitz, Alexxai V ^a   Golbe, Lawrence I ^c   Mark, Margery H ^c   Trojanowski, John Q ^a,b   Lee, Virginia M Y ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Alpha synuclein; Alzheimer's disease; Amyloid; Fibrillization; Lewy body; Microtubule associated protein tau; Neurodegenerative disease; Parkinson's disease; Synucleinopathies; Tauopathies

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID PROTEIN; TAU PROTEIN;

ARTICLE; BIOACCUMULATION; BIOCHEMISTRY; CONTROLLED STUDY; GENE CONTROL; GENE MUTATION; GENE STRUCTURE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MOLECULAR INTERACTION; NERVE DEGENERATION; NEUROPATHOLOGY; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DETERMINATION; SOLUBILITY; STATISTICAL SIGNIFICANCE; ULTRASTRUCTURE;

ALPHA-SYNUCLEIN; AMINO ACID SUBSTITUTION; BRAIN; BRAIN CHEMISTRY; DISEASE PROGRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MACROMOLECULAR SUBSTANCES; MALE; MIDDLE AGED; MUTATION; NERVE TISSUE PROTEINS; NEUROFIBRILLARY TANGLES; PARKINSON DISEASE; SOLUBILITY; SYNUCLEINS; TAU PROTEINS;

EID: 2342556414     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.expneurol.2004.01.007     Document Type: Article

References (30)

1. Baba M., Nakajo S., Tu P.H., Tomita T., Nakaya K., Lee V.M., Trojanowski J.Q., Iwatsubo T. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am. J. Pathol. 152:1998;879-884
2. Braak H., Braak E., Yilmazer D., Schultz C., de Vos R.A., Jansen E.N. Nigral and extranigral pathology in Parkinson's disease. J. Neural Transm., Suppl. 46:1995;15-31
3. Bramblett G.T., Goedert M., Jakes R., Merrick S.E., Trojanowski J.Q., Lee V.M. Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron. 10:1993;1089-1099
4. Conway K.A., Harper J.D., Lansbury P.T. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nat. Med. 4:1998;1318-1320
5. Crystal A.S., Giasson B.I., Crowe A., Kung M.P., Zhuang Z.P., Trojanowski J.Q., Lee V.M. A comparison of amyloid fibrillogenesis using the novel fluorescent compound K114. J. Neurochem. 86:2003;1359-1368
6. Duda J.E., Giasson B.I., Gur T.L., Montine T.J., Robertson D., Biaggioni I., Hurtig H.I., Stern M.B., Gollomp S.M., Grossman M., Lee V.M., Trojanowski J.Q. Immunohistochemical and biochemical studies demonstrate a distinct profile of alpha-synuclein permutations in multiple system atrophy. J. Neuropathol. Exp. Neurol. 59:2000;830-841
7. Duda J.E., Giasson B.I., Mabon M.E., Lee V.M., Trojanowski J.Q. Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases. Ann. Neurol. 52:2002;205-210
8. Duda J.E., Giasson B.I., Mabon M.E., Miller D.C., Golbe L.I., Lee V.M., Trojanowski J.Q. Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred. Acta Neuropathol. (Berlin). 104:2002;7-11
9. Forno L.S. Neuropathology of Parkinson's disease. J. Neuropathol. Exp. Neurol. 55:1996;259-272
10. Galvin J.E., Giasson B., Hurtig H.I., Lee V.M., Trojanowski J.Q. Neurodegeneration with brain iron accumulation, type 1 is characterized by alpha-, beta-, and gamma-synuclein neuropathology. Am. J. Pathol. 157:2000;361-368
11. Galvin J.E., Lee V.M., Trojanowski J.Q. Synucleinopathies: clinical and pathological implications. Arch. Neurol. 58:2001;186-190
12. Giasson B.I., Uryu K., Trojanowski J.Q., Lee V.M. Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro. J. Biol. Chem. 274:1999;7619-7622
13. Giasson B.I., Duda J.E., Murray I.V., Chen Q., Souza J.M., Hurtig H.I., Ischiropoulos H., Trojanowski J.Q., Lee V.M. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science. 290:2000;985-989
14. Giasson B.I., Jakes R., Goedert M., Duda J.E., Leight S., Trojanowski J.Q., Lee V.M. A panel of epitope-specific antibodies detects protein domains distributed throughout human alpha-synuclein in Lewy bodies of Parkinson's disease. J. Neurosci. Res. 59:2000;528-533
15. Giasson B.I., Forman M.S., Higuchi M., Golbe L.I., Graves C.L., Kotzbauer P.T., Trojanowski J.Q., Lee V.M. Initiation and synergistic fibrillization of tau and alpha-synuclein. Science. 300:2003;636-640
16. Goedert M., Jakes R. Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization. EMBO J. 9:1990;4225-4230
17. Golbe L.I., Di Iorio G., Bonavita V., Miller D.C., Duvoisin R.C. A large kindred with autosomal dominant Parkinson's disease. Ann. Neurol. 27:1990;276-282
18. Golbe L.I., Di Iorio G., Sanges G., Lazzarini A.M., La Sala S., Bonavita V., Duvoisin R.C. Clinical genetic analysis of Parkinson's disease in the Contursi kindred. Ann. Neurol. 40:1996;767-775
19. Greenberg S.G., Davies P., Schein J.D., Binder L.I. Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. J. Biol. Chem. 267:1992;564-569
20. Kotzbauer P.T., Trojanowsk J.Q., Lee V.M. Lewy body pathology in Alzheimer's disease. J. Mol. Neurosci. 17:2001;225-232
21. Kruger R., Kuhn W., Muller T., Woitalla D., Graeber M., Kosel S., Przuntek H., Epplen J.T., Schols L., Riess O. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 18:1998;106-108
22. Lee V.M., Goedert M., Trojanowski J.Q. Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24:2001;1121-1159
23. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 276:1997;2045-2047
24. Rodriguez E.M., Yulis R., Peruzzo B., Alvial G., Andrade R. Standardization of various applications of methacrylate embedding and silver methenamine for light and electron microscopy immunocytochemistry. Histochemistry. 81:1984;253-263
25. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., Goedert M. Alpha-synuclein in Lewy bodies. Nature. 388:1997;839-840
26. Spillantini M.G., Crowther R.A., Jakes R., Cairns N.J., Lantos P.L., Goedert M. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci. Lett. 251:1998;205-208
27. Spillantini M.G., Crowther R.A., Jakes R., Hasegawa M., Goedert M. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc. Natl. Acad. Sci. U. S. A. 95:1998;6469-6473
28. Spira P.J., Sharpe D.M., Halliday G., Cavanagh J., Nicholson G.A. Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr alpha-synuclein mutation. Ann. Neurol. 49:2001;313-319
29. Tu P.H., Galvin J.E., Baba M., Giasson B., Tomita T., Leight S., Nakajo S., Iwatsubo T., Trojanowski J.Q., Lee V.M. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein. Ann. Neurol. 44:1998;415-422
30. Zhukareva V., Mann D., Pickering-Brown S., Uryu K., Shuck T., Shah K., Grossman M., Miller B.L., Hulette C.M., Feinstein S.C., Trojanowski J.Q., Lee V.M. Sporadic Pick's disease: a tauopathy characterized by a spectrum of pathological tau isoforms in gray and white matter. Ann. Neurol. 51:2002;730-739